Segui
Domenico Ciliberto
Domenico Ciliberto
AOU Mater Domini Catanzaro
Email verificata su materdominiaou.it - Home page
Titolo
Citata da
Citata da
Anno
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials
D Ciliberto, C Botta, P Correale, M Rossi, M Caraglia, P Tassone, ...
European journal of cancer 49 (3), 593-603, 2013
1682013
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials
D Ciliberto, U Prati, L Roveda, V Barbieri, N Staropoli, A Abbruzzese, ...
Oncology reports 27 (6), 1849-1856, 2012
1132012
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
C Botta, V Barbieri, D Ciliberto, A Rossi, D Rocco, R Addeo, N Staropoli, ...
Cancer biology & therapy 14 (6), 469-475, 2013
1082013
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET …
MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ...
Cancer biology & therapy 12 (9), 780-787, 2011
1032011
Nanoparticle albumin bound paclitaxel in the treatment of human cancer: nanodelivery reaches prime‐time?
I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ...
Journal of Drug Delivery 2013 (1), 905091, 2013
992013
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
C Botta, D Ciliberto, M Rossi, N Staropoli, M Cuce, T Galeano, ...
Blood advances 1 (7), 455-466, 2017
682017
Postinfectious functional gastrointestinal disorders in children: a multicenter prospective study
L Pensabene, V Talarico, D Concolino, D Ciliberto, A Campanozzi, ...
The Journal of Pediatrics 166 (4), 903-907. e1, 2015
622015
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials
N Staropoli, D Ciliberto, C Botta, L Fiorillo, A Grimaldi, S Lama, ...
Cancer biology & therapy 15 (6), 707-720, 2014
612014
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic …
P Correale, C Botta, MS Rotundo, A Guglielmo, R Conca, A Licchetta, ...
Journal of Immunotherapy 37 (1), 26-35, 2014
582014
The Era of PARP inhibitors in ovarian cancer:“Class Action” or not? A systematic review and meta-analysis
N Staropoli, D Ciliberto, T Del Giudice, E Iuliano, M Cuce, F Grillone, ...
Critical Reviews in Oncology/Hematology 131, 83-89, 2018
462018
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
C Botta, MT Di Martino, D Ciliberto, M Cuce, P Correale, M Rossi, ...
Blood Cancer Journal 6 (12), e511-e511, 2016
452016
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
C Giofrè, F Scicchitano, C Palleria, C Mazzitello, M Ciriaco, L Gallelli, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S55-S60, 2013
452013
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
D Ciliberto, N Staropoli, F Caglioti, S Gualtieri, L Fiorillo, S Chiellino, ...
Cancer biology & therapy 16 (8), 1148-1159, 2015
382015
Immunotherapy of colorectal cancer: new perspectives after a long path
P Correale, C Botta, D Ciliberto, P Pastina, R Ingargiola, S Zappavigna, ...
Immunotherapy 8 (11), 1281-1292, 2016
292016
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis
MA Siciliano, G Caridà, D Ciliberto, M d’Apolito, C Pelaia, D Caracciolo, ...
ESMO open 7 (3), 100465, 2022
272022
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: a classic and Bayesian meta-analysis
D Ciliberto, N Staropoli, F Caglioti, S Chiellino, A Ierardi, R Ingargiola, ...
Critical reviews in oncology/hematology 125, 69-77, 2018
272018
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer
D Ciliberto, N Staropoli, S Chiellino, C Botta, P Tassone, P Tagliaferri
Pancreatology 16 (2), 249-258, 2016
252016
GOLFIG chemo-immunotherapy in metastatic colorectal cancer patients. A critical review on a long-lasting follow-up
M Caraglia, P Correale, R Giannicola, N Staropoli, C Botta, P Pastina, ...
Frontiers in oncology 9, 1102, 2019
212019
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: A first-in-human, phase 1, open-label …
P Tassone, MT Di Martino, M Arbitrio, L Fiorillo, N Staropoli, D Ciliberto, ...
Journal of hematology & oncology 16 (1), 68, 2023
172023
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine
P Correale, C Botta, N Staropoli, V Nardone, P Pastina, C Ulivieri, ...
Oncotarget 9 (29), 20539, 2018
142018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20